US Broker Ratings

Senseonics Holdings, Inc. (SENS) Investor Outlook: Analyzing a 212% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may find Senseonics Holdings, Inc. (SENS) an intriguing prospect. With a market capitalization of $247.19 million, this U.S.-based company is a key player..

Aurora Cannabis Inc. (ACB) Stock Analysis: 39.62% Potential Upside Beckons Investors

Aurora Cannabis Inc. (NYSE: ACB) is garnering attention from investors with its significant potential upside of 39.62%. This Canadian-based company, operating in the Healthcare sector under the Drug Manufacturers –..

Pacific Biosciences of California (PACB) Investor Outlook: Exploring a 25.38% Potential Upside in the Volatile Medical Devices Sector

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a key player in the healthcare sector, specifically in the medical devices industry, has been capturing investor attention with its cutting-edge sequencing solutions...

Quhuo Limited (QH) Stock Analysis: Navigating the Gig Economy with Caution Amidst a Rollercoaster 52-Week Range

Quhuo Limited (QH), a player in the gig economy platform space, is emerging from China with a diverse array of services designed to cater to modern lifestyle needs. As a..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Potential 91.57% Upside with Strong Buy Ratings

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to gene therapy. Headquartered in Hayward, California, Benitec focuses on..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: A Potential 251% Upside with Promising Analyst Ratings

Heron Therapeutics, Inc. (HRTX) presents an intriguing opportunity for investors focused on the biotechnology sector. With a market capitalization of $234.7 million, Heron is a commercial-stage biotech company based in..

Sprout Social, Inc (SPT) Stock Analysis: Assessing a 58% Potential Upside in a Competitive Market

Sprout Social, Inc (NASDAQ: SPT) stands as a formidable player in the technology sector, specializing in software applications for social media management. Headquartered in Chicago, Illinois, the company provides a..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a Promising 58% Upside and Biotech Innovations

Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage biopharmaceutical company, has been drawing attention in the biotechnology sector with its innovative approach to tackling genetically defined diseases. Based in Cambridge, Massachusetts,..

Zhengye Biotechnology Holding L (ZYBT): Investor Outlook Amidst a Challenging Year

Zhengye Biotechnology Holding L (NASDAQ: ZYBT) sits at the intersection of healthcare innovation and agricultural needs, focusing on the production and sale of veterinary vaccines. Based in Jilin, China, and..

National Research Corporation (NRC) Stock Analysis: A Healthcare Insights Leader with Robust ROE

National Research Corporation (NRC) stands at the intersection of healthcare and technology, providing critical analytics and insights that empower healthcare organizations to enhance both patient and employee experiences. Headquartered in..

Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 357.75% Potential Upside in the Healthcare Sector

Neuronetics, Inc. (NASDAQ: STIM), a prominent player in the medical devices industry, is capturing the attention of investors with its significant growth potential. Headquartered in Malvern, Pennsylvania, Neuronetics is known..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Unveiling a 446% Potential Upside

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stands at the forefront of biotechnology innovation, focused on developing mRNA-based therapeutic solutions for infectious diseases and rare genetic disorders. With its cutting-edge LUNAR..

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 41.68% Potential Upside in the Healthcare Sector

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector, primarily focuses on the design and manufacture of X-ray imaging components. Operating through two distinct segments—Medical and Industrial—Varex..

XOMA Royalty Corporation (XOMA) Stock Analysis: Unveiling a 148% Upside Potential

XOMA Royalty Corporation (NASDAQ: XOMA) offers an intriguing prospect for investors looking to tap into the biotechnology sector’s lucrative potential. As a biotech royalty aggregator, XOMA operates in a niche..

Outset Medical, Inc. (OM) Stock Analysis: Evaluating the 302% Upside Potential

Outset Medical, Inc. (NASDAQ: OM), a pioneer in the healthcare sector with its innovative hemodialysis solutions, presents a compelling investment opportunity, especially for risk-tolerant investors intrigued by high potential returns...

Viemed Healthcare, Inc. (VMD) Stock Analysis: Exploring a 78% Upside Potential for Investors

Viemed Healthcare, Inc. (NASDAQ: VMD) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Lafayette, Louisiana, Viemed specializes in providing home medical equipment..

NANO-X IMAGING LTD (NNOX) Stock Report: Exploring the 173% Potential Upside

Nano-X Imaging Ltd (NASDAQ: NNOX), a healthcare disruptor from Israel, is making waves in the medical devices industry with its cutting-edge digital X-ray technology. With a current market capitalization of..

Alpha Teknova, Inc. (TKNO) Stock Analysis: A Promising 118.98% Potential Upside Awaits Investors

Alpha Teknova, Inc. (TKNO), a key player in the healthcare sector, has been capturing investor attention with its innovative contributions to drug manufacturing, especially in the specialty and generic sub-industry...

Cytek Biosciences, Inc. (CTKB): Investor Outlook on a Potential 13.41% Upside

Cytek Biosciences, Inc. (NASDAQ: CTKB) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $648.27 million, this U.S.-based company is strategically..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Navigating Growth in the Biotech Sector with a 0.29% Potential Upside

Cidara Therapeutics, Inc. (NASDAQ: CDTX) stands at the forefront of the biotechnology sector with a focus on developing innovative therapies for critical medical conditions, notably invasive fungal infections and viral..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds